Who
John Walter Hanna Jr.
President and CEO
Company insider
Files Form 4 as: President and CEO, CareDx; Chief Commercial Officer, Veracyte.
In numbers
- Trades disclosed
- 135
- Buys
- 0
- Sells
- 24
- Bought
- $0
- Sold
- $21.6M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 3 Sep 2019
- Last trade
- 1 Oct 2026
- Last filed
- 5 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 5 Oct 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code F | $564K8,511 at $66.23 | filing |
| 16 Jul 2026filed 17 Jul 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code M | $968K118,000 at $8.20 | filing |
| 16 Jul 2026filed 17 Jul 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Sold | $1.8M50,000 at $36.11 | filing |
| 16 Jul 2026filed 17 Jul 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Sold | $2.7M68,000 at $39.01 | filing |
| 16 Jul 2026filed 17 Jul 2026 | CDNA CareDxoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —118,000 at $0.00 | filing |
| 16 Jul 2026filed 17 Jul 2026 | CDNA CareDxoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —118,000 at $0.00 | filing |
| 16 Jul 2026filed 17 Jul 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code M | $968K118,000 at $8.20 | filing |
| 16 Jul 2026filed 17 Jul 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Sold | $1.8M50,000 at $36.11 | filing |
| 16 Jul 2026filed 17 Jul 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Sold | $2.7M68,000 at $39.01 | filing |
| 1 Jul 2026filed 6 Jul 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code F | $249K8,511 at $29.25 | filing |
| 1 Jul 2026filed 6 Jul 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code F | $249K8,511 at $29.25 | filing |
| 29 Jun 2026filed 30 Jun 2026 | CDNA CareDxoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —39,900 at $0.00 | filing |
| 29 Jun 2026filed 30 Jun 2026 | CDNA CareDxoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —39,900 at $0.00 | filing |
| 29 Jun 2026filed 30 Jun 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code M | $327K39,900 at $8.20 | filing |
| 29 Jun 2026filed 30 Jun 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Sold | $1.2M39,900 at $29.24 | filing |
| 29 Jun 2026filed 30 Jun 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code M | $327K39,900 at $8.20 | filing |
| 29 Jun 2026filed 30 Jun 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Sold | $1.2M39,900 at $29.24 | filing |
| 26 Jun 2026filed 30 Jun 2026 | CDNA CareDxoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —100 at $0.00 | filing |
| 26 Jun 2026filed 30 Jun 2026 | CDNA CareDxoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —100 at $0.00 | filing |
| 26 Jun 2026filed 30 Jun 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code M | $820100 at $8.20 | filing |
News
CareDx (NASDAQ:CDNA) Hits New 1-Year High – Time to Buy?CDNA · dailypolitical.com · 21 Oct 2026CareDx (NASDAQ:CDNA) vs. Exicure (NASDAQ:XCUR) Head-To-Head ComparisonCDNA · dailypolitical.com · 20 Oct 2026
0 headlines in the last 90 days name John Walter Hanna Jr.; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.